mepenzolate has been researched along with Narcolepsy in 1 studies
mepenzolic acid: anticholinergic, antispasmodic agent; RN given refers to parent cpd; structure
Narcolepsy: A condition characterized by recurrent episodes of daytime somnolence and lapses in consciousness (microsomnias) that may be associated with automatic behaviors and AMNESIA. CATAPLEXY; SLEEP PARALYSIS, and hypnagogic HALLUCINATIONS frequently accompany narcolepsy. The pathophysiology of this disorder includes sleep-onset rapid eye movement (REM) sleep, which normally follows stage III or IV sleep. (From Neurology 1998 Feb;50(2 Suppl 1):S2-S7)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Sudo, Y | 1 |
| Suhara, T | 1 |
| Honda, Y | 1 |
| Nakajima, T | 1 |
| Okubo, Y | 1 |
| Suzuki, K | 1 |
| Nakashima, Y | 1 |
| Yoshikawa, K | 1 |
| Okauchi, T | 1 |
| Sasaki, Y | 1 |
| Matsushita, M | 1 |
1 other study available for mepenzolate and Narcolepsy
| Article | Year |
|---|---|
Muscarinic cholinergic receptors in human narcolepsy: a PET study.
Topics: Adult; Animals; Benzilates; Brain; Carbon Radioisotopes; Central Nervous System Agents; Dogs; Humans | 1998 |